BI-4142

Cat. No. M21051

All AbMole products are for research use only, cannot be used for human consumption.

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.

BI-4142 is a HER2 exon 20 insertion mutant inhibitor being developed for non-small cell lung cancer (NSCLC), The IC50 value was 5 nM.

Molecular Weight	521.57
Formula	C28H27N9O2
CAS Number	2682003-36-5
Storage	Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month

Related EGFR/HER2 Products
Sevabertinib Sevabertinib is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor with antitumor activity.
BPIQ-I BPIQ-I (PD 159121) is a potent and ATP-competitive EGFR tyrosine kinase inhibitor..
HKI-357 HKI-357 is an irreversible dual inhibitor of EGFR and ERBB2 with IC50s of 34 nM and 33 nM, respectively.
SJF-1528 SJF-1528 is a potent EGFR PROTAC degrader with DC50 values of 39.2 nM and 736.2 nM for wild-type EGFR in OVCAR8 cells and Exon 20 Ins mutated EGFR in HeLa cells.
CH7233163 CH7233163 is a noncovalent ATP-competitive inhibitor for EGFR-Del19/T790M/C797S.

Catalog